Article
Association between zidovudine and adverse pregnancy outcomes/congenital malformations: A pharmacovigilance study using FAERS data
2025-08-24
Abstract excerpt
<h4>Background</h4> Zidovudine (AZT), a key antiretroviral drug used for HIV treatment and preventing mother-to-child transmission, has insufficient post-marketing pharmacovigilance regarding pregnancy outcomes and congenital disorders. <h4>Methods</h4> This pharmacovigilance study analyzed adverse event (AE) reports associated with zidovudine from the U.S. FDA Adverse Event Reporting System (FAERS) database (Q1...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0607e030-157a-50b5-b7a4-45cf015fae50
- DOI
- 10.1101/2025.08.19.25334037
